Amoxicillin + Potassium Clavulanate Suspension Suppliers & Bulk Manufacturers
Available Forms: Suspension
Available Strengths: 125 mg/31.25 mg per 5 mL, 250 mg/62.5 mg per 5 mL, 400 mg/57 mg per 5 mL
Reference Brands: Augmentin(US), Moxiclav(India), Clavox (LATAM)
Category:
Antibiotics
Amoxicillin-clavulanate suspension combines amoxicillin’s bacterial cell wall synthesis inhibition with clavulanate’s beta-lactamase enzyme inhibition, broadening antibacterial activity. It effectively treats resistant infections, offers rapid symptom relief, and is suitable for pediatric use. Benefits include wide-spectrum coverage, improved efficacy against beta-lactamase producing bacteria, and convenient oral administration.
Amoxicillin + Potassium Clavulanate Suspension is available in Suspension
and strengths such as 125 mg/31.25 mg per 5 mL, 250 mg/62.5 mg per 5 mL, 400 mg/57 mg per 5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Amoxicillin + Potassium Clavulanate Suspension is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Amoxicillin + Potassium Clavulanate Suspension can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Amoxicillin Potassium Clavulanate suspension is approved in the EU and US for treating bacterial infections, especially those caused by beta-lactamase-producing bacteria. In the EU, brands like Augmentin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data, with generic options available. Both regions require detailed dossiers and pharmacovigilance plans for initial approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for amoxicillin-clavulanate suspension, ensuring adherence to European and US standards for safe, effective antibiotic therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing